Articles tagged with Vaccine Research
This study identified PIBP4, a PRA protein, as a crucial component of the PigmR-mediated immune signaling pathway in rice. The absence of PIBP4 and its interacting partner OsRab5a compromised blast resistance by disrupting PigmR's microdomain localization.
Researchers at La Jolla Institute for Immunology have discovered a human antibody called mAb 3A6 that may prove useful against deadly outbreaks. The antibody was isolated from an Ebola survivor and found to block infection by binding to the viral stalk, offering protection at a very low dose.
A new University of Virginia study found that providing clear information and collaborative learning sessions between patients and healthcare providers increased willingness to get vaccinated. Sixty-three percent of patients reported a strong recommendation from their healthcare provider motivated them to get vaccinated.
A recent study found that cold temperatures allow the bird pink eye pathogen to survive on bird feeders for up to seven days, causing more severe disease in birds compared to warmer temperatures. Regular cleaning of feeder surfaces with bleach can help mitigate the spread of the disease.
A study of 1,700 people found that those who consumed more conservative news were less likely to be vaccinated, but a diverse media diet made them more likely to get vaccinated. People who got their news from an ideologically diverse array of sources were more critical thinkers and less likely to be misled by misinformation.
A therapeutic HPV vaccine targeting HPV16 could potentially eliminate precancerous cervical lesions, according to a phase II clinical trial. The vaccine showed significant regression and reduced lesion size in patients with HPV16-positive high-grade cervical intraepithelial neoplasia.
Researchers developed a nanoparticle-based vaccine that generates antibodies targeting conserved regions of sarbecovirus receptor-binding proteins, offering broader protection against multiple strains. The vaccine demonstrated strong antibody responses and protection in animal studies against diverse SARS-CoV-2 and other sarbecoviruses.
A new longitudinal study has provided unprecedented insights into human papillomavirus (HPV) infection dynamics. The study found that non-persistent infections exhibit a plateau in viral load before rapidly declining, while chronic infections show a strong correlation between immune cells and virus production. This research could infor...
Researchers found that rotavirus protein NSP4 is necessary and sufficient for disrupting calcium signaling in infected and uninfected cells, affecting disease severity. Manipulating NSP4 could lead to new approaches to prevent or treat rotavirus infections.
Researchers created new proteins using AI that bind to and neutralize deadly snake toxins, providing a safer alternative to traditional antivenoms. The study's results show an 80-100% survival rate in mice, offering potential benefits for people in developing countries.
A recent study highlights the need for targeted interventions to improve COVID-19 vaccine confidence among Black women in the US. Addressing historical traumas and providing clear safety information are crucial to building trust with this demographic.
Research from Radboud University Medical Center shows that lockdowns during the COVID-19 pandemic strengthened the immune system's response to microorganisms. The study found that after lockdowns, inflammation levels in the body were low but the immune system reacted more intensely to viruses and bacteria.
A recent study in the Netherlands has found that COVID-19 vaccination during pregnancy is not associated with adverse health outcomes in infants. The researchers analyzed data from over 3,600 participants and found no significant associations between maternal COVID-19 vaccination and neonatal health issues, including breathing difficul...
UC San Diego researchers identified the key reason for vaccine failures against Staphylococcus aureus: overabundance of interleukin-10 (IL-10) in B cells and helper T cells. Blocking IL-10 restores vaccine efficacy, suggesting a potential solution to combat this deadly bacterium.
Researchers created an advanced computational model to optimize maternal vaccine design and protect high-risk populations. The model helps reveal which antibodies can pass through effectively and when, enabling the development of safer, more effective vaccines.
The study found that early initiation of the HPV vaccine series led to significant improvements in vaccination rates across all racial and ethnic groups. Vaccination rates increased from 13.2% in 2019 to 42.2% in 2022, with notable increases for Hispanic or Latino, Black, Asian, and white patients.
The University of Arizona Health Sciences has received a second vote of support from Maricopa County, doubling its investment in the Center for Advanced Molecular and Immunological Therapies (CAMI) to $8 million. CAMI will accelerate novel therapies for cancers, autoimmune conditions, and infectious diseases, including COVID-19.
A study published in PLOS Global Public Health found that individuals with high credulity are more susceptible to fake news and vaccine hesitancy. Mistrust was also linked to conspiracy thinking and difficulty distinguishing between real and fake news, particularly in those exposed to childhood adversity.
A recent study published in Nature found that mother fleas can transmit the plague to their offspring, posing a significant threat to prairie dog colonies and other rodent populations. This discovery highlights the importance of understanding the role of animals in the dissemination of the disease.
Researchers found that brief scientific literacy interventions can undermine conspiracy beliefs, particularly those built on faulty reasoning. These interventions were most effective against novel conspiracies and among high-conspiracy groups.
The study utilized biocompatible polymethyl methacrylate microspheres for controlled antigen delivery, demonstrating improved immunogenicity of tetanus toxoid. Microsphere formulations showed significant immune response, with optimal polymer concentrations required to meet I.P. requirements.
A significant drop in cervical cancer mortality among US women younger than age 25 has been observed, according to a recent study published in JAMA Network. The findings indicate that widespread HPV vaccination is driving this decline, reducing the prevalence of HPV infection and subsequent cervical cancer incidence.
Researchers at MUSC Hollings Cancer Center found a significant reduction in cervical cancer deaths among young women due to HPV vaccination. The study revealed a 62% decline in mortality rates over the last decade.
A modeling study found that HPV vaccination programs for adults aged 27-45 years are more costly and less effective than vaccinating younger people. Vaccinating subgroups at higher risk of HPV infection may improve cost-effectiveness, but overall, it's unlikely to be efficient for cancer prevention.
Researchers at Scripps Research have analyzed the molecular structure of viral proteins and developed a more stable form to create effective vaccines. The new design may lead to combination vaccines that target both RSV and human metapneumovirus, reducing hospitalizations for vulnerable populations.
Researchers developed biocompatible polymethyl methacrylate microspheres for controlled antigen delivery. The formulation resulted in efficient uptake by macrophages and other antigen-presenting cells, eliciting a notable immune response.
A recent study found that electronic letter reminders highlighting the cardiovascular benefits of influenza vaccines increased vaccination rates among over 2 million adults in Denmark. The strategy showed a greater impact on those who have had a heart attack, improving flu shot rates by potentially being cardioprotective. The research ...
Researchers have made significant strides toward creating inhalable mRNA medicines using a novel lipid-polymer nanoparticle. The nanoparticles successfully deliver aerosols to mice's lungs and demonstrate uniform protein expression in tissues.
Researchers found that vaccinating earlier in pregnancy, closer to 32 weeks, could provide better protection against RSV for newborns. Maternal vaccination resulted in significantly higher and longer-lasting maternal and cord RSV antibody levels.
A survey of older adults with heart conditions found that their sexual health impacts mood and well-being, but most healthcare professionals do not offer this information. Patients favor conversations with healthcare professionals about sexual health, including topics like medication side effects and anxiety before sex.
A randomized clinical trial found that simultaneous administration of mRNA COVID-19 and inactivated influenza vaccines had comparable reactogenicity to sequential administration. This suggests a safe option for co-administration of these vaccines.
A team of MIT engineers has developed a new computational method for analyzing complex biological systems, including the immune system's response to tuberculosis vaccination. The approach uses probabilistic graphical networks to identify key interactions and mechanisms, shedding light on how vaccines induce immunity.
Researchers at Houston Methodist have identified a new strain of bacteria, Streptococcus dysgalactiae subspecies equisimilis (SDSE), linked to increasingly severe human infections. The study used integrative analysis to investigate the genome, transcriptome, and virulence of SDSE strains, shedding light on their molecular pathogenesis.
A new study at an allergy clinic in a diverse community found that self-identified non-White patients were less likely to show vaccine hesitancy than the White patient group. Ethnicities included in the study showed Black, Hispanic and Asian ethnicities with lower rates of refusal compared to Whites.
Researchers found that repeated mRNA vaccines enhance mucosal antibodies in nasal secretions, blocking viral entry and providing sustained protection. The immune responses generated by mRNA vaccines may persist longer than previously thought, offering hope for sustained protection against emerging COVID-19 variants.
Research led by ISGlobal reveals that children younger than five months of age may benefit from the RTS,S and R21 malaria vaccines if they live in areas with low malaria transmission, where mothers have less antibodies to the parasite. The study analyzed blood samples from over 600 children and infants and found that high levels of mat...
Dr. Fyodor Urnav proposes a set of initiatives to address the crisis, including pooling patients by syndrome and permitting multiple gene editors in a single Investigational New Drug application. This approach aims to accelerate the development of CRISPR therapies for rare genetic diseases.
A multi-state study published in The Lancet found the RSV vaccine to be highly effective in protecting older adults against severe disease, hospitalization, and death. The vaccine provided approximately 80% protection against these outcomes, including severe disease and ICU admission.
A new study found that COVID-19 infection increased the risk of heart attack and stroke for up to three years after infection. The risk was higher among people with A, B or AB blood types compared to type O, according to researchers analyzing data in the UK Biobank.
Researchers at La Jolla Institute for Immunology have developed six lines of humanized mice to study human cases of COVID-19, shedding light on SARS-CoV-2's movement through the body and varying symptoms. The models help understand how different genetic backgrounds influence disease progression.
Washington University School of Medicine researchers will study how vaccines trigger long-lasting immune responses, comparing them with effective lifelong immune responses. They aim to understand factors that enable enduring immunity after vaccination and inform the design of nasal vaccines for respiratory viruses.
A multinational study found that people with unmedicated mental illness are less likely to be vaccinated against COVID-19, with a 9% lower vaccination rate compared to the general population. Individuals with substance use disorder were also 16% less likely to receive the vaccine.
A modelling study suggests that slow waning of MMR vaccine-induced immunity may contribute to rising measles cases in double-vaccinated people. However, the MMR vaccine remains the most effective measure to prevent measles infection, and community vaccination levels above 95% are essential to prevent outbreaks.
Researchers at MIT found that a two-dose schedule for an HIV vaccine can generate a strong response to the virus, outperforming a traditional seven-dose regimen. The first dose primes the immune system, helping it to produce antibodies more effectively when a larger dose is administered one week later.
A new study reveals that two specific genes in the RNA interference pathway play a crucial role in preventing virus transmission from parent to progeny in plants. This discovery could lead to healthier crops and potentially reduce the transmission of diseases like Zika from mothers to human children.
A new study found that RSV vaccination programs targeting older adults with underlying health conditions are more likely to be cost-effective than general age-based strategies. Vaccinating people aged 70 years and older with chronic medical conditions is likely to be cost-effective based on commonly used cost-effectiveness thresholds.
A team of researchers from Osaka University has pinpointed the B cells responsible for boosting COVID-19 immunity after vaccination. They found that activated atypical B cells are the main responders to mRNA vaccines, providing a new way to assess vaccine response and underlying biology.
A new study from Tulane University found that state-level COVID-19 vaccination mandates increased vaccine rates among health care workers by 3-4%, with improvements seen in states that required vaccinations without opt-outs. The policy was particularly effective among health care workers between the ages of 25-49 years.
A new Swedish registry study found that girls with mental illness or neurodevelopmental conditions have lower HPV vaccination coverage compared to their peers. The study involved over 115,000 girls and found significant differences in vaccination rates among those with psychiatric diagnoses or receiving psychotropic medications.
A European study found that prior smallpox vaccination in childhood could offer protection against infections caused by monkeypox virus (MPXV) clade II in men. The estimated degree of protection varied among countries, highlighting the need for further research.
A recent study has confirmed the efficacy and safety of the dengue vaccine TAK-003, which reduces the risk of contracting the disease by over 50%. The vaccine has shown a high safety profile, with more than 90% of adults and children developing antibodies after administration.
A new study by Prof. Eyal Klement and PhD Student Michal Morgenstern has identified key factors influencing vaccination intentions among Israeli dairy farmers, revealing the significant impact of social pressure and underscoring the need for improved communication between veterinarians and farmers.
A new zwitterionic polymer complex has been developed to deliver plasmid DNA into skeletal muscle, achieving widespread gene expression in mice. This breakthrough could lead to new therapies for serious muscular diseases.
Researchers at the University of Chicago have discovered that small molecules can induce trained immunity in innate immune cells, which can fight off seasonal infections and diseases without vaccines. The team found that certain steroids, known to suppress inflammation, can also stimulate a strong immune response.
A study published in JAMA Network Open found no association between RSV vaccination during late pregnancy and increased risk of preterm birth or poor outcomes. The research provides real-world evidence supporting the safety of Pfizer's Abrysvo vaccine, offering reassurance to patients and clinicians.
Researchers at Boston Children's Hospital have discovered a promising vaccine adjuvant called PVP-037, which enhances the immune response to vaccines. The compound, an imidazopyrimidine molecule, targets innate immune cells and stimulates a broader immune response.
Researchers describe a new concept for an immune response against cancer and aging using senescent cell-derived vaccines. The vaccines aim to stimulate the immune system against cancer cells and slow down or reverse aging-related diseases.
Researchers have discovered how a neutralizing antibody blocks measles virus infection by arresting the fusion process. The study's findings may also be relevant to other viruses with pandemic potential, such as Nipah and parainfluenza viruses.
Researchers found that H5N1 virus particles in unpasteurized milk can remain stable on metal and rubber components of commercial milking equipment for over an hour. This increases the potential for bird flu exposure among dairy farm workers and animal-to-animal transmission.
A global meta-analysis of 1.8m women found COVID-19 vaccination reduces the risk of infection during pregnancy by 61% and hospitalization by 94%. Vaccination also lowers caesarean section risk by 9%, hypertensive disorders in pregnancy by 12%, and intensive care unit admission for newborns by 8%.